Clinical Trial Update: Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT

View source ↗

Summary

This clinical trial update reports prognostic outcomes for patients with relapsed or refractory Hodgkin lymphoma treated with IGEV induction therapy before high…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Hodgkin's Lymphoma | Status: COMPLETED